Non-randomised study designs are frequently used by researchers in cardiovascular nursing and allied professions. Baseline differences between the groups to be compared may introduce bias in the results. Methods for causal inference address this issue. One such method is propensity weighting, in which two or more treatments/exposure groups are weighted to make the groups as comparable as possible. As such, it mimics a randomised controlled trial design. In this article, the Twang package is presented for propensity weighting, and its use is exemplified in a study on smoking and cannabis consumption in adults with congenital heart disease.
TengCHChenSYWeiYC, et alEffects of sarcopenia on functional improvement over the first year after cardiac surgery: a cohort study. Eur J Cardiovasc Nurs2019; 18: 309–317.
2.
SaitoHKagiyamaNNaganoN, et alSocial isolation is associated with 90-day rehospitalization due to heart failure. Eur J Cardiovasc Nurs2019; 18: 16–20.
3.
DanielisMChittaroMDe MonteA, et alA five-year retrospective study of out-of-hospital cardiac arrest in a north-east Italian urban area. Eur J Cardiovasc Nurs2019; 18: 67–74.
4.
WuYCTungHHWeiJ.Quality of life, demoralization syndrome and health-related lifestyle in cardiac transplant recipients – a longitudinal study in Taiwan. Eur J Cardiovasc Nurs2019; 18: 149–162.
5.
ThomasELotfalianyMGraceSL, et alEffect of cardiac rehabilitation on 24-month all-cause hospital readmissions: a prospective cohort study. Eur J Cardiovasc Nurs2019; 18: 234–244.
6.
JaarsmaTDeatonCFitzsimmonsD, et alResearch in cardiovascular care: a position statement of the Council on Cardiovascular Nursing and Allied Professionals of the European Society of Cardiology. Eur J Cardiovasc Nurs2014; 13: 9–21.
7.
AustinPC.An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res2011; 46: 399–424.
8.
RidgewayGMcCaffreyDMorralA, et alToolkit for weighting and analysis of nonequivalent groups: a tutorial for the twang package. Santa Monica, CA: Rand, 2017.
9.
RosenbaumPRRubinDB.The central role of the propensity score in observational studies for causal effects. Biometrika1983; 70: 41–55.
10.
LiuHZhuDCaoJ, et alThe effects of a standardized nursing intervention model on immobile patients with stroke: a multicenter study in China. Eur J Cardiovasc Nurs. Epub ahead of print 4 September 2019. DOI: 1474515119872850.
11.
LiLGreeneT.A weighting analogue to pair matching in propensity score analysis. Int J Biostats2013; 9: 215–234.
12.
BurgetteLGriffinBAMcCaffreyD.Propensity scores for multiple treatments: a tutorial for the mnps function in the twang package. Santa Monica, CA: Rand, 2017.
13.
McCaffreyDFGriffinBAAlmirallD, et alA tutorial on propensity score estimation for multiple treatments using generalized boosted models. Stat Med2013; 32: 3388–3414.
14.
MoonsPLuyckxKKovacsAH, et alPrevalence and effects of cigarette smoking, cannabis consumption and co-use in adults with congenital heart disease from 15 countries. Can J Cardiol (in press). DOI: 10.1016/j.cjca.2019.07.635.
15.
MoonsPKovacsAHLuyckxK, et alPatient-reported outcomes in adults with congenital heart disease: inter-country variation, standard of living and healthcare system factors. Int J Cardiol2018; 251: 34–41.
16.
HolbeinCEPeughJVeldtmanGR, et alHealth behaviours reported by adults with congenital heart disease across 15 countries. Eur J Prev Cardiol (in press) 2019. DOI: 2047487319876231.
17.
GoossensELuyckxKMommenN, et alHealth risk behaviors in adolescents and emerging adults with congenital heart disease: psychometric properties of the Health Behavior Scale-Congenital Heart Disease. Eur J Cardiovasc Nurs2013; 12: 544–557.
18.
WareJEKosinskiMTurner-BowkerDM, et alUser’s Manual for the SF-12 v2 Health Survey, 2nd edn.QualityMetric, Incorporated, 2009: Lincoln, RI.
MoonsPVan DeykKDe BleserL, et alQuality of life and health status in adults with congenital heart disease: a direct comparison with healthy counterparts. Eur J Cardiovasc Prev Rehabil2006; 13: 407–413.
21.
MoonsPVan DeykKMarquetK, et alProfile of adults with congenital heart disease having a good, moderate, or poor quality of life: a cluster analytic study. Eur J Cardiovasc Nurs2009; 8: 151–157.
22.
DienerEEmmonsRALarsenRJ, et alThe satisfaction with life scale. J Pers Assess1985; 49: 71–75.
23.
ApersSKovacsAHLuyckxK, et alAssessment of Patterns of Patient-Reported Outcomes in Adults with Congenital Heart disease – International Study (APPROACH-IS): rationale, design, and methods. Int J Cardiol2015; 179: 334–342.
24.
RubinDB.Using propensity scores to help design observational studies: application to the tobacco litigation. Health Serv Outcomes Res Methodol2001; 2: 169–188.
25.
BangHRobinsJM.Doubly robust estimation in missing data and causal inference models. Biometrics2005; 61: 962–973.
26.
MoonsPVan DeykKDedroogD, et alPrevalence of cardiovascular risk factors in adults with congenital heart disease. Eur J Cardiovasc Prev Rehabil2006; 13: 612–616.
27.
MoonsPDe GeestSBudtsW.Comprehensive care for adults with congenital heart disease: expanding roles for nurses. Eur J Cardiovasc Nurs2002; 1: 23–28.
28.
ThometCMoonsPBudtsW, et alStaffing, activities, and infrastructure in 96 specialised adult congenital heart disease clinics in Europe. Int J Cardiol2019; 292: 100–105.
29.
MoonsPHildersonDVan DeykK.Implementation of transition programs can prevent another lost generation of patients with congenital heart disease. Eur J Cardiovasc Nurs2008; 7: 259–263.
